Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 Jun;53(6):498–500. doi: 10.1136/thx.53.6.498

Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels

C Kroegel 1, M Schuler 1, M Forster 1, R Braun 1, P R Grahmann 1
PMCID: PMC1745234  PMID: 9713451

Abstract

BACKGROUND—Increased serum levels of eosinophil cationic protein (ECP) have been detected in adolescent patients with cystic fibrosis. However, ECP concentrations in adult patients with bronchiectasis unrelated to cystic fibrosis have not been studied.
METHODS—Eosinophil numbers and serum concentrations of ECP were determined in 14 patients with known or newly diagnosed bronchiectasis and compared with age and sex matched patients with allergic bronchial asthma, chronic obstructive pulmonary disease (COPD), and controls in whom bronchiectasis or obstructive pulmonary disease could be excluded.
RESULTS—Serum ECP levels were significantly raised both in patients with bronchiectasis (median (range) 22.5 µg/l (7-85)) and allergic asthma (35.0 µg/l (7-128)) compared with the sex and age matched subjects suffering from COPD (6.7 µg/l (1.5-28); p<0.006) and non-obstructive normal controls (7.5 µg/l (3.5-19); p<0.003). In contrast, significantly increased peripheral eosinophil numbers were observed in patients with bronchial asthma (305 × 106/l; p<0.01) but not in those with bronchiectasis (102 × 106/l), COPD (117 × 106/l), and healthy controls (101 × 106/l).
CONCLUSIONS—The discrepancy between eosinophil counts and eosinophil numbers in patients with bronchiectasis suggests that serum ECP levels may be more relevant in assessing local eosinophil involvement than blood eosinophil numbers.



Full Text

The Full Text of this article is available as a PDF (112.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azzawi M., Johnston P. W., Majumdar S., Kay A. B., Jeffery P. K. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis. 1992 Jun;145(6):1477–1482. doi: 10.1164/ajrccm/145.6.1477. [DOI] [PubMed] [Google Scholar]
  2. Elliott M. W., Simonds A. K., Carroll M. P., Wedzicha J. A., Branthwaite M. A. Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life. Thorax. 1992 May;47(5):342–348. doi: 10.1136/thx.47.5.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Griffin E., Håkansson L., Formgren H., Jörgensen K., Peterson C., Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol. 1991 Feb;87(2):548–557. doi: 10.1016/0091-6749(91)90014-f. [DOI] [PubMed] [Google Scholar]
  4. Koller D. Y., Götz M., Eichler I., Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax. 1994 May;49(5):496–499. doi: 10.1136/thx.49.5.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Koller D. Y., Urbanek R., Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med. 1995 Aug;152(2):629–633. doi: 10.1164/ajrccm.152.2.7633718. [DOI] [PubMed] [Google Scholar]
  6. Leger P., Bedicam J. M., Cornette A., Reybet-Degat O., Langevin B., Polu J. M., Jeannin L., Robert D. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest. 1994 Jan;105(1):100–105. doi: 10.1378/chest.105.1.100. [DOI] [PubMed] [Google Scholar]
  7. Meecham Jones D. J., Paul E. A., Jones P. W., Wedzicha J. A. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med. 1995 Aug;152(2):538–544. doi: 10.1164/ajrccm.152.2.7633704. [DOI] [PubMed] [Google Scholar]
  8. Moreschi M. A., Fiel S. B. An update on bronchiectasis. Curr Opin Pulm Med. 1995 Mar;1(2):119–124. [PubMed] [Google Scholar]
  9. Okubadejo A. A., Paul E. A., Jones P. W., Wedzicha J. A. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J. 1996 Nov;9(11):2335–2339. doi: 10.1183/09031936.96.09112335. [DOI] [PubMed] [Google Scholar]
  10. Reimert C. M., Giwercman B., Høiby N., Kharazmi A. Eosinophil cationic protein in sputum from cystic fibrosis patients with Pseudomonas aeruginosa infections. Lancet. 1994 Nov 26;344(8935):1504–1505. doi: 10.1016/s0140-6736(94)90322-0. [DOI] [PubMed] [Google Scholar]
  11. Shneerson J. M. The changing role of mechanical ventilation in COPD. Eur Respir J. 1996 Mar;9(3):393–398. doi: 10.1183/09031936.96.09030393. [DOI] [PubMed] [Google Scholar]
  12. Strumpf D. A., Millman R. P., Carlisle C. C., Grattan L. M., Ryan S. M., Erickson A. D., Hill N. S. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991 Dec;144(6):1234–1239. doi: 10.1164/ajrccm/144.6.1234. [DOI] [PubMed] [Google Scholar]
  13. Venge P., Roxin L. E., Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol. 1977 Nov;37(3):331–335. doi: 10.1111/j.1365-2141.1977.tb01003.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES